The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX–Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist
A pyrazolone compound acting as a formyl peptide receptor (FPR) 2/ALX–selective agonist has been reported, but its pharmacological activities on human FPRs (hFPRs) and mouse FPRs (mFprs) have not been well demonstrated. In this study, we found that this compound, designated as compound A, induced co...
Main Authors: | Yoshitaka Sogawa, Akiko Shimizugawa, Takao Ohyama, Hiroaki Maeda, Kazuki Hirahara |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319310990 |
Similar Items
-
Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
by: Sergio Sánchez-García, et al.
Published: (2023-11-01) -
Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
by: Youwen Zhuang, et al.
Published: (2022-02-01) -
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis
by: Letizia Crocetti, et al.
Published: (2021-10-01) -
Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
by: Vivian Vasconcelos Costa, et al.
Published: (2022-03-01) -
Behavioral changes in FPR2/ALX and Chemr23 receptor knockout mice are exacerbated by prenatal alcohol exposure
by: Sandra M. Mooney, et al.
Published: (2023-07-01)